Skip to main content

Table 1 Clinical, biochemical and hematologic parameters (n = 47 patients)

From: Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study

Height (cm) 167 ± 11
Weight (kg) 73 ± 20
Dialysis vintage (months) 44 ± 44
Diabetes mellitus 45 %
History of coronary artery disease 28 %
History of cerebrovascular disease 6 %
History of peripheral vascular disease 17 %
AV fistula 68 %
Supine pre-dialysis systolic blood pressure (mmHg) 143 ± 17
Supine pre-dialysis diastolic blood pressure (mmHg) 79 ± 9
Standing pre-dialysis systolic blood pressure (mmHg) 147 ± 20
Standing pre-dialysis diastolic blood pressure (mmHg) 83 ± 10
Inter-dialytic weight gain (L) 2.7 ± 0.9
Medication use  
  ASA 62 %
  ACE inhibitor 42 %
  Angiotensin II receptor blocker 49 %
  Statin 51 %
  ESA 98 %
PRU 74 ± 10 %
Plasma albumin (g/L) 34 ± 5
Plasma calcium (mmol/L) 2.16 ± 0.20
Plasma phosphate (mmol/L) 1.75 ± 0.53
Plasma alkaline phosphatase (IU/L) 153 ± 210
Hemoglobin (g/L) 113 ± 12
Plasma ferritin (pM) 396 ± 313
Total iron saturation 24 ± 11 %
Fasting total cholesterol (mmol/L) 4.03 ± 0.70
Fasting LDL cholesterol (mmol/L) 2.01 ± 0.43
Fasting HDL cholesterol (mmol/L) 1.09 ± 0.30
Fasting triglycerides (mmol/L) 2.08 ± 1.15
  1. Values are Mean (or median) +/− SD (or interquartile range)
  2. PRU Percent reduction of Urea